Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/14
End: 04/30/14
Due: 04/30/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects | NCT02088398 | Acetylon Pharmaceuticals Incorporated | user2@example.com | None | 2014-03-31 | 2014-04-30 | 2015-04-30 | - | - | 2025-07-14 |